Brain Tumor Pathology

Papers
(The TQCC of Brain Tumor Pathology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Intraspinal ASPSCR1::TFE3 rearranged tumor with nerve differentiation49
Preface for Brain Tumor Pathology vol.41 issue 215
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recu15
Double-hit primary central nervous system lymphoma with histogenetically proven bone marrow infiltration: a case report and a review of the literature14
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis14
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas14
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma14
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement14
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment11
Targeting TGF-β signaling in glioblastoma: therapeutic implications and novel drug development strategies11
Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis11
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next11
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma10
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next9
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors9
Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lym8
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation7
Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma6
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis6
Three-dimensional visualization of human brain tumors using the CUBIC technique6
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles6
Preface for Brain Tumor Pathology vol. 39 issue 26
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas5
Integrated analysis of MYC expression, 8q24.21 copy number, and recurrence patterns in astrocytoma, IDH-mutant5
Integrated analysis of multiple methods reveals characteristics of the immune microenvironment in medulloblastoma5
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report5
Triple sellar collision lesion: a unique case of pituitary adenoma, Rathke cleft cyst, and xanthogranuloma—case report and systematic review of the literature5
Revisiting the definition of glioma recurrence based on a phylogenetic investigation of primary and re-emerging tumor samples: a case report5
Timing of H3K27me3 loss in secondary anaplastic meningiomas5
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment5
0.033783197402954